# FDA Inspection 1044406 - EirGen Pharma Ltd - February 09, 2018

Source: https://www.keypedia.com/records/fda_inspections/eirgen-pharma-ltd/38df6883-00ec-43b2-9c16-2cdf1cedbe90
Source feed: FDA_Inspections

> FDA Inspection 1044406 for EirGen Pharma Ltd on February 09, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044406
- Company Name: EirGen Pharma Ltd
- Inspection Date: 2018-02-09
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276330 - 2023-10-13](https://www.keypedia.com/records/fda_inspections/eirgen-pharma-ltd/13dfe087-fc4c-4d3a-a6ea-2cee4222a730)
- [FDA Inspection 892754 - 2014-08-15](https://www.keypedia.com/records/fda_inspections/eirgen-pharma-ltd/6e9e2366-994b-43c5-8d9b-a59dc72a9c0c)
- [FDA Inspection 803013 - 2012-09-14](https://www.keypedia.com/records/fda_inspections/eirgen-pharma-ltd/d2e1a038-233b-4d62-ae96-d2db2dd911b1)
- [FDA Inspection 695356 - 2010-09-21](https://www.keypedia.com/records/fda_inspections/eirgen-pharma-ltd/04a7295f-2337-4458-a6d6-d0fd47ddaeb6)

Company: https://www.keypedia.com/companies/eirgen-pharma-ltd/f9a682ae-b665-4341-814c-af610c74a3ec

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c